Notice2022-19242
Solicitation of Nominations for Membership To Serve on the Advisory Commission on Childhood Vaccines
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
September 7, 2022
Issuing agencies
Health and Human Services DepartmentHealth Resources and Services Administration
Abstract
HRSA is seeking nominations of qualified candidates for consideration for appointment as members of the Advisory Commission on Childhood Vaccines (ACCV). The ACCV advises the Secretary of HHS (Secretary) on issues related to implementation of the National Vaccine Injury Compensation Program (VICP). HRSA is seeking nominations of qualified candidates to fill vacancies on the ACCV.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 172 (Wednesday, September 7, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 172 (Wednesday, September 7, 2022)]
[Notices]
[Pages 54700-54701]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-19242]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Solicitation of Nominations for Membership To Serve on the
Advisory Commission on Childhood Vaccines
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services (HHS).
ACTION: Request for nominations.
-----------------------------------------------------------------------
SUMMARY: HRSA is seeking nominations of qualified candidates for
consideration for appointment as members of the Advisory Commission on
Childhood Vaccines (ACCV). The ACCV advises the Secretary of HHS
(Secretary) on issues related to implementation of the National Vaccine
Injury Compensation Program (VICP). HRSA is seeking nominations of
qualified candidates to fill vacancies on the ACCV.
DATES: Written nominations for membership on the ACCV will be received
on a continuous basis.
ADDRESSES: Nomination packages must be submitted to the Director,
Division of Injury Compensation Programs, Health Systems Bureau, HRSA,
5600 Fishers Lane, Room 08N146B, Rockville, Maryland 20857. Candidates
can submit electronic nomination packages by email to Pita Gomez at
<a href="/cdn-cgi/l/email-protection#7c3d3f3f2a3c140e0f1d521b130a"><span class="__cf_email__" data-cfemail="8acbc9c9dccae2f8f9eba4ede5fc">[email protected]</span></a>.
FOR FURTHER INFORMATION CONTACT: Pita Gomez, Principal Staff Liaison,
Division of Injury Compensation Programs, Health Systems Bureau, HRSA
at (301) 945-9386 or email at <a href="/cdn-cgi/l/email-protection#09484a4a5f49617b7a68276e667f"><span class="__cf_email__" data-cfemail="2667656570664e54554708414950">[email protected]</span></a>. A copy of the ACCV charter
and list of the current membership is available on the ACCV website at
<a href="https://www.hrsa.gov/advisory-committees/vaccines/index.html">https://www.hrsa.gov/advisory-committees/vaccines/index.html</a>.
SUPPLEMENTARY INFORMATION: The ACCV was established by Title XXI of the
Public Health Service Act (the Act) and advises the Secretary on issues
related to implementation of the VICP. The ACCV meets at least four
times each calendar year.
Nominations: HRSA is requesting nominations for voting members to
serve as Special Government Employees (SGEs) on the ACCV to fill open
positions. The Secretary appoints members with the expertise needed to
fulfill the duties of the ACCV. The
[[Page 54701]]
membership requirements are set forth in section 2119 of the National
Childhood Vaccine Injury Act.
The ACCV consists of nine voting members appointed by the Secretary
as follows: (1) Three health professionals, who are not employees of
the U.S. government, and who have expertise in the health care of
children, the epidemiology, etiology, and prevention of childhood
diseases, and the adverse reactions associated with vaccines, of whom
at least two shall be pediatricians; (2) three members from the general
public, of whom at least two shall be legal representatives (parents or
guardians) of children who have suffered a vaccine-related injury or
death; and (3) three attorneys, of whom at least one shall be an
attorney whose specialty includes representation of persons who have
suffered a vaccine-related injury or death, and of whom one shall be an
attorney whose specialty includes representation of vaccine
manufacturers. In addition, the Director of the National Institutes of
Health, the Assistant Secretary for Health, the Director of the Centers
for Disease Control and Prevention, and the Commissioner of the Food
and Drug Administration (or the designees of such officials) serve as
non-voting ex officio members.
HHS will consider nominations of all qualified individuals with a
view to ensure that the ACCV includes the areas of subject matter
expertise noted above. As indicated above, at least two of the three
ACCV members of the general public must be legal representatives
(parents or guardians) of children who have suffered a vaccine-related
injury or death. Because those members must be the legal
representatives of children who have suffered a vaccine-related injury
or death, to be considered for appointment to the ACCV in that
category, there must have been a finding (i.e., a decision) by the U.S.
Court of Federal Claims or a civil court that a VICP-covered vaccine
caused, or was presumed to have caused, the represented child's injury
or death. Additionally, based on a recommendation made by the ACCV, the
Secretary will consider having a health professional with expertise in
obstetrics as one of the members of the general public. Interested
applicants may self-nominate or be nominated by another individual or
organization.
Individuals selected for appointment to the Committee will be
invited to serve for up to 3 years. Members are appointed as SGEs and
receive a stipend and reimbursement for per diem and travel expenses
incurred for attending ACCV meetings and/or conducting other business
on behalf of the ACCV, as authorized by 5 U.S.C. 5703 for persons
employed intermittently in government service.
The following information must be included in the package of
materials submitted for each individual nominated for consideration:
(1) a letter of nomination stating the name, affiliation, and contact
information for the nominee, the basis for the nomination (i.e., what
specific attributes, perspectives, and/or skills does the individual
possess that would benefit the workings of the ACCV) and the nominee's
field(s) of expertise; (2) the name, address, daytime telephone number,
and email address at which the nominator can be contacted; and (3) a
current copy of the nominee's curriculum vitae. The individual being
nominated or the person/organization recommending the candidate may
submit nomination packages directly to HRSA, which will collect and
retain nomination packages to create a pool of possible future ACCV
voting members. When a vacancy occurs, HRSA and HHS will review
nomination packages from the appropriate category and nominees may be
contacted at that time.
HHS endeavors to ensure that the membership of the ACCV is fairly
balanced in terms of points of view represented and that individuals
from a broad representation of geographic areas, gender, and ethnic and
minority groups, as well as individuals with disabilities, are
considered for membership. Appointments shall be made without
discrimination on the basis of race, age, ethnicity, national origin,
gender, disability, sexual orientation, or cultural, religious, or
socioeconomic status.
Individuals who are selected to be considered for appointment will
be required to provide detailed information regarding their financial
holdings, consultancies, and research grants or contracts. Disclosure
of this information is required for HRSA ethics officials to determine
whether there is a potential conflict of interest between the SGE's
public duties as a member of the ACCV and their private interests,
including an appearance of a loss of impartiality as defined by federal
laws and regulations, and to identify any required remedial action
needed to address the potential conflict.
Authority: Under the authorities that established the ACCV, the
Federal Advisory Committee Act of October 6, 1972, (Pub. L. 92-463) and
section 2119 of the National Childhood Vaccine Injury Act (Pub. L. 99-
660, as amended), HRSA is requesting nominations for voting members of
the ACCV.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2022-19242 Filed 9-6-22; 8:45 am]
BILLING CODE 4165-15-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on September 7, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.